| 2022/07 | 2023/07 | 2024/07 | 2025/07 | 2026/07 | |
|---|---|---|---|---|---|
| Net Sales(million yen) | 33,911 | 26,400 | 20,359 | 16,160 | 13,883 |
| Operating Profit(million yen) | 2,414 | -611 | 139 | 617 | 494 |
| Ordinary Profit(million yen) | 2,572 | -631 | 161 | 599 | 602 |
| Profit Attributable to Owners of Parent(million yen) | 1,424 | -733 | -1,483 | 471 | 364 |
| Basic Earnings Per Share(yen) | 163.35 | -84.17 | -170.10 | 54.10 | 41.77 |
| Total Assets(million yen) | 12,300 | 12,135 | 11,002 | 10,140 | 10,244 |
| Net Assets(million yen) | 8,348 | 7,609 | 6,124 | 6,610 | 6,957 |
| Capital Adequacy Ratio(%) | 67.9 | 62.7 | 55.7 | 65.1 | 67.6 |
Note 1: The Company conducted a 20-for-1 stock split of shares of common stock on August 29, 2020, based on a resolution passed at an extraordinary meeting of the Board of Directors held on August 20, 2020. Earnings per share are retroactively presented for prior periods.
Note 2: The Company has prepared consolidated financial statements since the second quarter of the fiscal year ended July 31, 2021. Figures prior to the second quarter of the fiscal year ended July 31, 2021 are those of Premier Anti-Aging on a non-consolidated basis.
Caution
-
These data are prepared based on the financial results reports.
-
The frequency of updates may change in accordance with changes to the format of the financial results reports.
-
Please see the financial results reports and other materials for detailed information regarding the settlement of accounts.
-
The contents of these data will not immediately reflect corrections to the financial results reports when announced.
-
While we pay due caution to the conversion of data for the posting, please note that there is a possibility that errors may occur in the information due to uncontrollable circumstances, such as the unauthorized alteration of contents by a third party or mechanical defects resulting from equipment malfunction.
-
Service provided by Nomura Investor Relations Co., Ltd.
Powered by ShareWith
